Effective Nov. 9, 2022, the company's prospectus supplement dated Nov. 9, 2022, to the short form base shelf prospectus dated Dec. 1, 2020, was filed with and accepted by the TSX Venture Exchange.

The exchange has been advised that closing occurred on Nov. 15, 2022, for gross proceeds of $34,517,250 (including the exercise of the overallotment option).

Underwriters:  Canaccord Genuity Corp. and PI Financial Corp. (together the co-lead underwriters), and Raymond James Ltd., H.C. Wainwright & Co. LLC, Roth Canada Inc., and Stifel Nicolaus Canada Inc.

Offering:  23,805,000 units (including those shares issued pursuant to the exercise of the overallotment option) (Each unit is exercisable into one common share in the capital of the company and one-half of one share purchase warrant.)

Unit price:  $1.45 per unit

Warrant exercise price/term:  Each whole warrant is exercisable at $2 per share at any time prior to Nov. 15, 2024.

Underwriters' commissions:  An aggregate cash payment of $2,071,035, being equal to 6 per cent of the gross proceeds of the supplement offering, and 1,428,300 non-transferable compensation warrants consisting of units were issued to the underwriters and may be exercised at $1.45 per compensation warrant share at any time prior to Nov. 15, 2024.

Overallotment option:  The company granted to the underwriters an option to purchase additional units, up to 15 per cent of the offering. The overallotment option was exercised in full at closing, equal to 3,105,000 units at $1.45 per unit.

Please refer to the company's news releases dated Nov. 7, 2022, Nov. 8, 2022, and Nov. 15, 2022, for further details.